The Gross Law Firm Notifies Baxter International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BAX

(NYSE:BAX), NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to […]

Dallas Theater Center and North Texas Food Bank Join Forces to Bring Hope This Holiday Season

Dallas Theater Center and North Texas Food Bank Join Forces to Bring Hope This Holiday Season Holiday production of A Christmas Carol to benefit neighbors facing hunger GlobeNewswire November 24, 2025 Dallas, TX, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Dallas Theater Center (DTC) and the North Texas Food Bank (NTFB) are celebrating the season

DexCom, Inc. Class Action: The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 – DXCM

DexCom, Inc. Class Action: The Gross Law Firm Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 26, 2025 – DXCM GlobeNewswire November 24, 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).

James Hardie Industries plc. Sued for Securities Law Violations – Contact The Gross Law Firm Before December 23, 2025 to Discuss Your Rights – JHX

James Hardie Industries plc. Sued for Securities Law Violations – Contact The Gross Law Firm Before December 23, 2025 to Discuss Your Rights – JHX GlobeNewswire November 24, 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders

The Gross Law Firm Notifies Baxter International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BAX

The Gross Law Firm Notifies Baxter International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BAX GlobeNewswire November 24, 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the

The Gross Law Firm Reminds Stride Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 – LRN

The Gross Law Firm Reminds Stride Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 – LRN GlobeNewswire November 24, 2025 NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Stride, Inc. (NYSE: LRN). Shareholders who purchased shares

MONTEFIORE EINSTEIN ADDRESSES YOUTH MENTAL HEALTH CRISIS WITH UNVEILING OF INPATIENT CENTER FOR CHILDREN AND ADOLESCENTS

New 21-Bed Inpatient Pediatric Mental Health Center Adds Critical Care Beds to Address Urgent Behavioral and Mental Health Needs in The Bronx, Nearly Doubling Inpatient Capacity Today, Governor Kathy Hochul and Dr. Philip Ozuah, President and CEO of Montefiore Einstein, were joined by New York State Office of Mental Health Commissioner Dr. Ann Marie Sullivan,

Investors in MoonLake Immunotherapeutics Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights – MLTX

(NASDAQ:MLTX), NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX). Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

Shareholders that lost money on Skye Bioscience, Inc. (SKYE) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

(NasdaqGM:SKYE), NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

Scroll to Top